Terbinafine

BreastfeedingPediatric
  • TRADE NAME: Lamisil (Novartis)
  • INDICATIONS: Fungal infections of the skin and nails
  • CLASS: Antifungal
  • HALF-LIFE: ~36 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Amitriptyline, Amphotericin B, Atomoxetine, Caffeine, Carbamazepine, Cimetidine, Codeine, Conivaptan, Cyclosporine, CYP2D6 substrates, Desipramine, Estrogens, Fesoterodine, Fluconazole, Nebivolol, Progestogens, Rifampin, Rifapentine, Saxagliptin, Tamoxifen, Tamsulosin, Tetrabenazine, Thioridazine, Tramadol, Tricyclic antidepressants

PREGNANCY CATEGORY: B

Our database has 69 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
HEMATOLOGIC
OTIC
OCULAR
LOCAL
OTHER


Page last updated 08/14/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric